Patrick Harrison Carroll - 28 Feb 2024 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Reporting relationship: Chief Medical Officer, Director
Issuer ticker: HIMS
Reported as of: 28 Feb 2024
Net transaction value: -$263,800
SEC form: 4
Accepted by SEC: 01 Mar 2024, 16:07:54 UTC
Prior SEC filing: 19 Dec 2023
Next SEC filing: 19 Mar 2024
Source filing: View source filing
Reporting owner signature: /s/ Alexandra Cotter Wilkins, Attorney-in-Fact

Key filing fact

Patrick Harrison Carroll filed Form 4 for Hims & Hers Health, Inc. (HIMS) on 01 Mar 2024.

Key facts

This page summarizes Patrick Harrison Carroll's Form 4 filing for Hims & Hers Health, Inc. (HIMS).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 01 Mar 2024, 16:07.

Change

Previous filing in this sequence was filed on 19 Dec 2023.
Current net transaction value: -$263,800.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HIMS transaction

Class A Common Stock

Sale

Transaction value: $263,800
Shares: -20,000
Change %: -11%
Price: $13.19
Shares after: 154,835
Date: 28 Feb 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HIMS transaction Derivative

Restricted Stock Unit

Award

Transaction value: $0
Shares: +77,433
Change %
Price: $0.000000
Shares after: 77,433
Date: 28 Feb 2024
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 77,433
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

Footnote F2

The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.